• The Lead Podcast - Episode 99: A Discussion of Artificial Intelligence for Individualized Treatment...

  • Apr 10 2025
  • Length: 17 mins
  • Podcast

The Lead Podcast - Episode 99: A Discussion of Artificial Intelligence for Individualized Treatment...

  • Summary

  • Join host and Digital Education Chair Prashanthan Sanders, MBBS, PhD, FHRS, as he discusses this article from Nature with guests Anand N Ganesan, MBBS, PhD, and Tina Baykaner, MD, MPH. This trial was also presented as a late-breaking clinical trial at Heart Rhythm 2024.

    https://www.hrsonline.org/education/TheLead
    https://www.nature.com/articles/s41591-025-03517-w

    Host Disclosure(s):

    P. Sanders:
    Honoraria/Speaking/Consulting: Boston Scientific, Abbott Medical
    Research: Boston Scientific, Abbott, Medtronic, Becton Dickinson, CathRx,
    Pacemate, Kalyan Technologies, Ceryx Medical, Biosense Webster, Inc., Hello Alfred, Abbott Medical; Membership on Advisory Committees: Pacemate, Medtronic PLC, Boston Scientific, CathRx, Abbott Medical

    Contributor Disclosure(s):
    A. Ganesan: Honoraria/Speaking/Consulting: Biosense Webster, Inc.
    T. Baykaner: Honoraria/Speaking/Consulting: Medtronic, Pacemate, Volta Medical, iRhythm Technologies; Research: NIH

    This episode is worth 0.25 ACE credits. If you want credit for listening to this episode, please visit the episode page on HRS365: https://www.heartrhythm365.org/URL/TheLeadEpisode99

    Show more Show less
adbl_web_global_use_to_activate_webcro768_stickypopup

What listeners say about The Lead Podcast - Episode 99: A Discussion of Artificial Intelligence for Individualized Treatment...

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.